| Literature DB >> 34754277 |
Ibrahim Mssillou1, Abdelkrim Agour1, Noureddine Hamamouch2, Badiaa Lyoussi1, Elhoussine Derwich1,3.
Abstract
In this study, the polyphenol content and the antioxidant and antimicrobial activities of hydroethanolic (MVE) and hydroacetonic (MVA) leaf extracts of Marrubium vulgare L. were examined. The results indicated that the total phenolic content was higher in MVA (112.09 ± 4.77 mg GAE/DW) compared to MVE extract (98.77 ± 1.68 mg GAE/DW). The total flavonoid content was also higher in MVA extract (21.08 ± 0.38 mg QE/g DW) compared to MVE (17.65 ± 0.73 mg QE/g DW). Analysis of the chemical composition revealed the presence of 13 compounds with a total of 96.14%, with the major compound being malic acid (22.57%). Both extracts possess a good total antioxidant activity. DPPH and FRAP assays indicated that the MVE extract possesses a better antioxidant activity, with IC50 = 52.04 µg/mL ± 0.2 and EC50 of 4.51 ± 0.5 mg/mL, compared to MVA extract (IC50 = 60.57 ± 0.6 µg/mL and EC50 of 6.43 ± 0.0411 mg/mL). Moreover, both extracts exhibited strong antimicrobial activity against certain nosocomial strains as indicted by the MIC values, which ranged between 0.93 mg/mL and 10 mg/mL. Taken together, these results reveal the importance of M. vulgare as a natural antioxidant with important antimicrobial activity.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34754277 PMCID: PMC8572620 DOI: 10.1155/2021/7011493
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1TPC, TFC, and TTC in mg (gallic acid, quercetin, and ascorbic acid, respectively) equivalent/gram dry weight of two extracts from Marrubium vulgare L. The results are expressed by means ± standard deviation, and values with different letters are significantly different (P < 0.05).
Phytochemical composition of M. vulgare extract.
| Peak | Compounds | Formula | RT (min) | % area |
|---|---|---|---|---|
| 1 | Cyclotetrasiloxane, octamethyl- (CAS) | C8H24O4Si4 | 8.22 | 3.02 |
| 2 | Silanol, trimethyl-, phosphate (3 : 1) | C9H27O4PSi3 | 9.16 | 19.08 |
| 3 | 4-p-Tolylcyclohexene | C13H16 | 10.45 | 3.77 |
| 4 | Malic acid (tms) | C13H30O5Si3 | 10.80 | 22.57 |
| 5 | Xylitol 5TMS | C20H52O5Si5 | 12.42 | 3.00 |
| 6 | Spiro[1,3-dithiane-2,4′-cyclopent[c]isoxazolidine] | C9H15NOS2 | 12.99 | 4.63 |
| 7 | D-Xylofuranose, 1,2,3,5-tetrakis-O-(trimethylsilyl)- | C17H42O5Si4 | 13.05 | 2.97 |
| 8 | D-Galactose 5TMS | C21H52O6Si5 | 13.47 | 4.35 |
| 9 | Galactose oxime hexaTMS | C24H61NO6Si6 | 13.73 | 9.94 |
| 10 | Alpha-D-galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)- | C21H52O6Si5 | 13.85 | 9.10 |
| 11 | 6,7-Bis(trimethylsilyl)-1,3-dimethoxyisoquinoline | C17H27NO2Si2 | 14.25 | 2.90 |
| 12 | Trimethylsilyl-meso-inositol | C24H60O6Si6 | 14.63 | 7.00 |
| 13 | Beta-D-galactofuranoside, ethyl 2,3,5,6-tetrakis-O-(trimethylsilyl)- | C20H48O6Si4 | 18.17 | 3.81 |
|
| ||||
| Total | 96.14 | |||
RT, retention time.
Antioxidant activities of M. vulgare extracts by DPPH, FRAP, and TAC methods.
| DPPH IC50 ( | FRAP EC50 (mg/mL) | TAC (mg AAE/g DW) | |
|---|---|---|---|
| MVE | 52.04 ± 0.2a | 4.51 ± 0.5a | 218.58 ± 19.24b |
| MVA | 60.57 ± 0.6a | 6.43 ± 0.0411a | 273.52 ± 16.67b |
| Ascorbic acid | — | 2.19 ± 0.9a | — |
| BHT | 9.28 ± 0.2b | — | — |
Values in the same column sharing different letters are significantly different at P < 0.05.
Inhibition zone of MVE and MVA extracts of M. vulgare leaves against pathogenic microbial strains.
| Microbial strains | Inhibition zone diameter (mm) | |||
|---|---|---|---|---|
| MVE | MVA | Tetracycline | Imazalil | |
| Gram-positive | ||||
| | 10.33 ± 0.33 | 10 ± 0.5 | 30 ± 1.5 | NT |
|
| ||||
| Gram-negative | ||||
| | 11.66 ± 0.66 | NA | 8.33 ± 0.66 | NT |
| | 8 ± 0.5 | NA | 19 ± 0.5 | NT |
|
| ||||
| Fungus | ||||
| | 8 ± 0.5 | 6 ± 0.5 | NT | 14 ± 1 |
| | 7.33 ± 0.33 | NA | NT | 14.33 ± 0.66 |
Results are expressed by means ± standard deviation; for each value, the test was performed in triplicate (n = 3). NT, not tested; NA, not active.
MICs and MBC/MFCs (mg/mL) of MVE and MVA extracts.
| Pathogens | MICa and MBC/MFCb (mg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|
| MVE | MVA | Tetracycline | Imazalil | |||||
| MIC | MBC | MIC | MBC | MIC | MBC | MIC | MFC | |
| Gram-positive bacteria | ||||||||
| | 2.5 | 2.5 | 3.75 | 3.75 | 0.25 | 0.25 | NT | NT |
| | 1.87 | 1.87 | 10 | 10 | 0.062 | 0.25 | NT | NT |
|
| ||||||||
| Gram-negative bacteria | ||||||||
| | 2.5 | 2.5 | 3.75 | 3.75 | 0.25 | 0.5 | NT | NT |
| | 5 | 5 | 2.5 | 2.5 | 0.5 | 0.75 | NT | NT |
|
| ||||||||
| Fungal species | ||||||||
| | 1.75 | 2.5 | 0.93 | 1.75 | NT | NT | 0.05 | 0.05 |
| | 10 | >10 | 10 | >10 | NT | NT | 0.1 | 0.1 |
aMinimum inhibitory concentration. bMinimum bactericidal/fungicidal concentration. NT, not tested.